In vivo ESR studies on subcutaneously injected multilamellar liposomes in living mice

Pharmaceutical Research

Volumn 21, Issue 11, 2004, Pages 2017-2024

  Moll, Klaus Peter ^a   Stößer, Reinhard ^b   Herrmann, Werner ^a   Borchert, Hans Hubert ^a   Utsumi, Hideo ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

In vivo ESR; Liposomes; Spin exchange; Subcutaneous

Indexed keywords

2,2,6,6 TETRAMETHYL 4 TRIMETHYLAMMONIUM PIPERIDINE 1 OXYL IODIDE; CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL; LIPOSOME; NITROXIDE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG; DRUG CARRIER;

ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENCAPSULATION; FEMALE; HYDROGENATION; LASER DIFFRACTION; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; SKIN; SUSTAINED DRUG RELEASE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; HAIRLESS MOUSE; SPIN LABELING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; INJECTIONS, SUBCUTANEOUS; LIPOSOMES; MICE; MICE, INBRED HRS; PHOSPHATIDYLCHOLINES; SPIN LABELS;

EID: 21644461152     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000048192.13398.ac     Document Type: Article

References (24)

1. T. Yamaguchi, S. Itai, H. Hayashi, S. Soda, A. Hamada, and H. Utsumi. In vivo ESR studies on pharmacokinetics and metabolism of parenteral lipid emulsions in living mice. Pharm. Res. 13:729-733 (1996).
2. G. Storm, C. Oussoren, P. A. M. Peeters, and Y. Barenholz. Tolerability of liposomes in vivo. In G. Gregoriadis (ed.), Liposomes as Drug Carriers, J. Wiley & Sons, New York, 1988, pp. 345-383
3. C. Oussoren, M. Velinova, G. Scherphof, J. J. van der Want, N. van Rooijen, and G. Storm. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes. Biochim. Biophys. Acta 1370:259-272 (1998).
4. C. Oussoren, J. Zuidema, D. J. A. Crommelin, and G. Storm. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim. Biophys. Acta 1328:261-272 (1997).
5. I. Babai, S. Samira, Y. Barenholz, Z. Zakay-Rones, and E. Kedar. A novel influenza subunit vaccine composed of liposome-encapsulted haemagglutinin/ neuramidase and IL-2 or GM-CSF. I. Vaccine characterisation and efficacy studies in mice. Vaccine 17:1223-1238 (1999).
6. M. L. Corvo, O. C. Boermann, W. J. G. Oyen, J. C. S. Jorge, M. E. M. Cruz, D. J. A. Crommelin, and G. Storm. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: In vivo fate and therapeutic activity in an inflamation model. Pharm. Res. 17:600-606 (2000).
7. C. Oussoren, W. M. C. Elling, D. J. A. Crommelin, G. Storm, and J. Zuidema. The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim. Biophys. Acta 1369:159-172 (1998).
8. S. Mantripragada. A lipid based depot (DepoFoam® technology) for sustained release drug delivery. Prog. Lipid Res. 41:392-406 (2002).
9. M. P. Ramprasad, G. M. Anatharamaiah, D. W. Garber, and N. V. Katre. Sustained-delivery of an apolipoprotein E-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels. J. Control. Rel. 79:207-218 (2002).
10. N. V. Katre, J. Asherman, H. Schaefer, and M. Hora. Multivesicular liposome (DepoFoam) technology for the sustained delivery of insulin-like growth factor-I (IGF-I). J. Pharm. Sci. 87:1341-1345 (1998).
11. M. L. van Slooten, O. Boerman, K. Romoren, E. Kedar, D. J. A. Crommelin, and G. Storm. Liposomes as sustained release system for human interferon-γ: Biopharmaceutical aspects. Biochim. Biophys. Acta 1530:134-145 (2001).
12. Homepage SkyePharma. http://www.Skyepharma.com, 2002.
13. K. Vrhovnik, J. Kristl, M. Sentjurc, and J. Smid-Korbar. Influence of liposome bilayer fluidity on the transport of encapsulated substance into the skin as evaluated by EPR. Pharm. Res. 15:525-530 (1998).
14. L. Coderch, J. Fonollosa, M. De Pera, J. Estelrich, A. De La Maza, and J. L. Parra. Influence of cholesterol on liposome fluidity by EPR: Relationship with percutaneous absorption. J. Control. Rel. 68:85-95 (2000).
15. L. Honzak, M. Sentjurc, and H. M. Swartz. In vivo EPR of topical delivery of a hydrophilic substance encapsulated in multilamellar liposomes applied to the skin of hairless and normal mice. J. Control Rel. 66:221-228 (2000).
16. D. J. Schneider and J. H. Freed. Calculating Slow Motional Magnetic Resonance Spectra. In L. J. Berliner and J. Reuben (eds.), Biological Magnetic Resonance, Vol. 8., Plenum Press, New York, 1989, pp. 1-76.
17. D. E. Budil, S. Lee, S. Saxena, and J. H. Freed. Nonlinear-least squares analysis of slow-motion EPR spectra in one and two dimensions using a modified Levenberg-Marquardt algorithm. J. Magn. Reson. 120:155-189 (1996).
18. J. H. Freed. Theory of Slow Tumbling ESR Spectra for Nitroxides. In L. J. Berliner (ed.), Spin Labeling, Theory and Applications, Academic Press, New York, 1976, pp. 53-132.
19. D. Pfeiffer. Computer program ISOTROP, Federal Institute for Materials Research and Testing, Berlin, Germany.
20. Yu. M. Molin, K. M. Salikhov, and K. I. Zamaraev. Spin Exchange, Springer, Berlin Heidelberg, 1980.
21. J. Fuchs. Free radical reduction by thioredoxin reductase. J. Invest. Dermatol. 91:92-93 (1988).
22. J. Fuchs, H. J. Freisleben, M. Podda, G. Zimmer, R. Milbradt, and L. Packer. Nitroxide radical biostability in skin. Free Rad. Biol. Med. 15:415-423 (1993).
23. K.-P. Moll. PhD Thesis, Humboldt-University of Berlin, Berlin, 2004, pp. 161-171.
24. J. Senior. Fate and behaviour of liposomes in vivo: a review of controlling factors. Crit. Rev. Therapeut. Drug Car. Syst. 3:123-193 (1987).